Loading...
NPI 1417450537 · Frisco, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ayass Lung Clinic, PLLC is a clinical medical laboratory provider located in Frisco, Texas. This profile covers 82 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Ayass Lung Clinic, PLLC |
| Address | 8501 Wade Blvd Ste 750 |
| City | Frisco |
| State | TX |
| ZIP | 75034 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 15, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $552K |
| Medicaid | $30.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
82 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 3,370 | $20 | $57.3K |
| 83520 | The lab analyst measures the analyte, which is not an infectious agent antibody or infectious agent antigen, by immunoassay. Use 83520 for procedures that have no specific code assigned for the… | 2,770 | $20 | $47.1K |
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 10 | $2,860 | $34.3K |
| 86146 | The lab analyst performs the technical lab test to analyze the sample, such as serum, for the presence of beta 2 glycoprotein I antibody. Report one unit for each antibody. | 1,020 | $30 | $25.6K |
| 86147 | The lab analyst performs the technical lab test to analyze for the presence of antibodies to cardiolipin, also called antiphospholipids. Report this code once for each immunoglobulin class the… | 1,020 | $30 | $25.5K |
| 86317 | The lab analyst performs an immunoassay to quantitate the patient’s specimen for antibodies to an infectious agent, not specified in another code. | 1,030 | $20 | $15.4K |
| 82172 | The lab analyst performs apolipoprotein testing on components of lipoprotein complexes that contain a variety of high, low, and very–low density lipoproteins. The three most important of these… | 630 | $20 | $13.2K |
| 83880 | The lab analyst measures the amount of natriuretic peptide, a hormone made by heart muscle cells, in the patient specimen. Blood levels of the hormone increase in patients with congestive heart… | 280 | $40 | $10.6K |
| 82784 | The lab analyst performs the technical lab test to analyze the concentration of a particular gamma globulin in the specimen. The analyst may test for immunoglobulin A, immunoglobulin D,… | 1,020 | $10 | $9.2K |
| 84238 | The lab analyst performs the technical lab assay to test a sample, such as serum, plasma, or tissue, for the presence of a nonendocrine receptor. | 230 | $40 | $8.4K |
Showing 1–10 of 82
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 82 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
82 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81317 | 16 | 20 | 220 | $660 | $382.7K |
| 81298 | 16 | 20 | 220 | $630 | $362.7K |
| 81307 | 17 | 20 | 150 | $660 | $361.4K |
| U0003 | 32 | 60 | 100 | $70 | $64.7K |
| 81455 | 5 | 10 | 30 | $2,790 | $64.2K |
| 86235 | 9 | 70 | 270 | $20 | $44K |
| 83520 | 4 | 20 | 570 | $20 | $36.6K |
| 86317 | 7 | 10 | 1,470 | $10 | $36K |
| 82172 | 11 | 20 | 520 | $20 | $31.8K |
| U0005 | 38 | 70 | 110 | $20 | $22.3K |
Showing 1–10 of 82
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 2,340 | $10 | $23.4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 2,230 | $1 | $6.7K |
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 78 | 340 | 400 | $50 | $553.5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 77 | 260 | 640 | $20 | $137.2K |
Other providers in the same ZIP code as Ayass Lung Clinic, PLLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Supreme Medical Laboratories LLC | TX | Clinical Medical Laboratory | $648K | $1.2M |
| Baylor Surgicare At Blue Star, LLC | TX | Ambulatory Surgical Clinic/Center | $563.4K | $0 |
| Fareha Kazi | TX | Internal Medicine Physician | $440K | $0 |
| Mark Mcquaid | TX | Surgery Physician | $371.1K | $0 |
| David Keelen | TX | Pain Medicine Physician | $324.2K | $0 |
| John Skiendzielewski | TX | Phlebology Physician | $280.8K | $0 |
| Brent Stevenson | TX | Sleep Medicine (Psychiatry & Neurology) Physician | $272.6K | $0 |
| Annaliese Majeed | TX | Physician Assistant | $222.3K | $0 |
| Andrew Morchower | TX | Interventional Pain Medicine Physician | $205.9K | $0 |
| Timothy Rodgers | TX | Dermatology Physician | $137.2K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.